Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Anemia, Refractory, with Excess of Blasts × Anthracyclines × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 6 Triple Negative Breast Neoplasms 2 Leukemia, Myeloid, Acute 2 Cardiotoxicity 2 Pathologic Complete Response 1 Neoplasms, Second Primary 1 Leukemia 1 Cardiovascular Diseases 1 Breast Cancer Early Stage Breast Cancer (Stage 1-3) 1

Interventions

Cyclophosphamide 15 fludarabine phosphate 12 Whole-Body Irradiation 12 Mycophenolic Acid 12 fludarabine 11 Tacrolimus 8 Peripheral Blood Stem Cell Transplantation 8 Busulfan 8 Melphalan 7 Granulocyte Colony-Stimulating Factor 5 Cyclosporine 5 Azacitidine 5 Filgrastim 4 venetoclax 3 Cord Blood Stem Cell Transplantation 3 Biopsy 3 thymoglobulin 2 decitabine and cedazuridine drug combination 2 Vorinostat 2 Thiotepa 2 Specimen Handling 2 Sirolimus 2 Rituximab 2 Methotrexate 2 Hematopoietic Stem Cell Transplantation 2 Etoposide 2 Cyclosporins 2 Clofarabine 2 Bone Marrow Transplantation 2 treosulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡